Recent work by Pan et al. (2022) recently confirmed that TSPYL2 is downregulated in PC and overexpression of TSPYL2 can effectively overcome gemcitabine resistance in PC cells. The gene discussed is TSPYL2; the disease is pachyonychia congenita.